Form 4 for EW Edwards Lifesciences
Accepted 2022-05-31 00:00:00 ET · period of report 2022-05-31 · accession 0001225208-22-007468 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-31 | 2022-05-31 | EW | Zovighian Bernard J | CVP, TMTT | S - Sale | $100.83 | -9,000 | 30.8K | -23% | -$907.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-31 | S | D | 9,000 | $100.83 | 30,816 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $100.83 to $100.85. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |